Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lucentis with or without micropulse diode laser for diabetic macular edema
2013-003056-21Phase 2Completed
- Sponsor
- GWT-TUD
- Start
- Dec 2013
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of ranibizumab in diabetic macular edema (DME) (2 arms), sponsored by GWT-TUD. Primary endpoint: Best corrected visual acuity (BCVA). Started Dec 2013; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2013-003056-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003056-21.